NARS2 Gene

NARS2 — Mitochondrial Asparaginyl-tRNA Synthetase

Overview

NARS2 encodes mitochondrial asparaginyl-tRNA synthetase (mtAsnRS), an essential enzyme for mitochondrial protein synthesis. This nuclear-encoded enzyme is imported into mitochondria where it catalyzes the attachment of asparagine to the appropriate mitochondrial tRNA, a critical step in mitochondrial translation[@sissler2017mtars]. Mutations in NARS2 cause a spectrum of mitochondrial disorders including Leigh syndrome, Leukoencephalopathy with thalamus and brainstem involvement (LBSL), and Perrault syndrome. Emerging research also suggests NARS2 dysfunction contributes to common neurodegenerative diseases including Alzheimer's disease (AD)[@tang2020nars2alzh] and Parkinson's disease (PD)[@chen2021nars2pd]. This page provides comprehensive information on NARS2's molecular function, disease associations, and therapeutic implications.

NARS2 — Mitochondrial Asparaginyl-tRNA Synthetase

Overview

NARS2 encodes mitochondrial asparaginyl-tRNA synthetase (mtAsnRS), an essential enzyme for mitochondrial protein synthesis. This nuclear-encoded enzyme is imported into mitochondria where it catalyzes the attachment of asparagine to the appropriate mitochondrial tRNA, a critical step in mitochondrial translation[@sissler2017mtars]. Mutations in NARS2 cause a spectrum of mitochondrial disorders including Leigh syndrome, Leukoencephalopathy with thalamus and brainstem involvement (LBSL), and Perrault syndrome. Emerging research also suggests NARS2 dysfunction contributes to common neurodegenerative diseases including Alzheimer's disease (AD)[@tang2020nars2alzh] and Parkinson's disease (PD)[@chen2021nars2pd]. This page provides comprehensive information on NARS2's molecular function, disease associations, and therapeutic implications.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Mitochondrial Asparaginyl-tRNA Synthetase</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>NARS2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitochondrial Asparaginyl-tRNA Synthetase</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>11q14.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[55830](https://www.ncbi.nlm.nih.gov/gene/55830)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[614946](https://www.omim.org/entry/614946)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000137558</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9HBJ5](https://www.uniprot.org/uniprotkb/Q9HBJ5/entry)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Aminoacyl-tRNA synthetase (class II)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~56 kDa</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Mitochondrial matrix</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Leigh syndrome, LBSL, Perrault syndrome, AD, PD</td></tr>
</table>
</div>

Molecular Biology and Biochemistry

Enzyme Function

Mitochondrial aminoacyl-tRNA synthetases (mtARS) are a family of 20 enzymes, each specifically charging one amino acid to its corresponding mitochondrial tRNA[@diodato2016mtars]. NARS2 (mtAsnRS) performs the following reaction:

tRNA^Asn + Asparagine + ATP → Asparaginyl-tRNA^Asn + AMP + PPi

This aminoacylation reaction occurs in the mitochondrial matrix and is essential for translating the 13 mitochondrial DNA-encoded proteins, all components of the oxidative phosphorylation (OXPHOS) system.

Protein Structure

NARS2 possesses the characteristic class II aminoacyl-tRNA synthetase domain structure:

Unlike cytoplasmic AsnRS, NARS2 contains additional sequences adapted for mitochondrial import and function.

Evolutionary Conservation

NARS2 is evolutionarily conserved from yeast to humans. The mitochondrial ARS family arose from a bacterial ancestor with subsequent adaptation to eukaryotic mitochondria. Human NARS2 shares significant homology with bacterial AsnRS but has acquired additional regulatory domains.

Cellular Functions

Mitochondrial Translation

NARS2 is essential for translating the 13 proteins encoded by mitochondrial DNA:

• Complex I subunits: ND1, ND2, ND3, ND4, ND4L, ND5, ND6
• Complex III subunits: CYTB
• Complex IV subunits: COX1, COX2, COX3
• Complex V subunits: ATP6, ATP8

OXPHOS Complex Assembly

Proper mitochondrial translation is critical for assembling the five OXPHOS complexes. NARS2 deficiency causes:

• Decreased Complex I activity
• Reduced Complex IV activity
• Impaired ATP production
• Increased reactive oxygen species (ROS) generation

Mitochondrial Dynamics

NARS2 dysfunction affects mitochondrial quality control:

• Impaired mitophagy initiation
• Altered mitochondrial network morphology
• Reduced mitochondrial DNA copy number
• Disrupted calcium handling

Expression Patterns

Tissue Distribution

NARS2 is expressed in all tissues with high energy demands:

• Brain: Particularly high in cerebellar Purkinje cells, hippocampal neurons, and cortical pyramidal cells
• Heart: Left ventricular myocardium
• Skeletal muscle: Type I (slow-twitch) fibers
• Liver: Hepatocytes
• Kidney: Renal tubules

Brain Expression

In the brain, NARS2 shows regional specificity:

• Cerebellum: Highest expression in Purkinje cells
• Hippocampus: CA1 and CA3 pyramidal neurons
• Cerebral cortex: Layer V pyramidal neurons
• Brainstem: Dopaminergic neurons of the substantia nigra

Developmental Regulation

NARS2 expression is developmentally regulated, with increased expression during neural development and gradual decline during aging. The age-related decrease in NARS2 expression may contribute to mitochondrial dysfunction in normal aging and neurodegenerative diseases.

Disease Associations

Leigh Syndrome (MIM #614946)

Biallelic NARS2 mutations cause a form of Leigh syndrome characterized by:

• Clinical features: Developmental regression, lactic acidosis, hypotonia, dystonia, ataxia
• Neuroimaging: Bilateral basal ganglia and brainstem lesions
• Biochemistry: Elevated lactate, decreased OXPHOS complex activity
• Prognosis: Progressive course, often fatal in childhood

LBSL (Leukoencephalopathy with Thalamus and Brainstem Involvement)

NARS2 mutations can cause LBSL with characteristic white matter abnormalities:

• Confluent T2/FLAIR hyperintensities in cerebral white matter
• Signal changes in thalamus and brainstem
• Progressive motor and cognitive decline

Perrault Syndrome

NARS2 is one of several genes causing Perrault syndrome:

• Sensorineural hearing loss (both sexes)
• Ovarian dysgenesis (females)
• Sometimes accompanied by neurological symptoms

Alzheimer's Disease

NARS2 dysfunction has been implicated in AD pathogenesis[@tang2020nars2alzh]:

Parkinson's Disease

In PD, NARS2 contributes to dopaminergic neuron vulnerability[@chen2021nars2pd]:

Therapeutic Implications

Gene Therapy Approaches

Small Molecule Therapies

Symptomatic Management

• Seizure control: Antiepileptic medications
• Movement disorder management: Dopamine replacement if needed
• Hearing rehabilitation: Cochlear implants for sensorineural hearing loss
• Nutritional support: Dietary modifications for feeding difficulties

Key Publications

See Also

• [Leigh Syndrome](/diseases/leigh-syndrome)
• [Mitochondrial Disorders](/diseases/mitochondrial-disorders)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics-in-neurodegeneration)
• [OXPHOS Complexes](/entities/oxidative-phosphorylation-complexes)
• [Mitochondrial Translation](/mechanisms/mitochondrial-translation-machinery)
• [OXPHOS Deficiency](/mechanisms/oxidative-phosphorylation-deficiency)
• [Perrault Syndrome](/diseases/perrault-syndrome)